Cargando…

High throughput analysis of B cell dynamics and neutralizing antibody development during immunization with a novel clade C HIV-1 envelope

A protective HIV-1 vaccine has been hampered by a limited understanding of how B cells acquire neutralizing activity. Our previous vaccines expressing two different HIV-1 envelopes elicited robust antigen specific serum IgG titers in 20 rhesus macaques; yet serum from only two animals neutralized th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mopuri, Rohini, Welbourn, Sarah, Charles, Tysheena, Ralli-Jain, Pooja, Rosales, David, Burton, Samantha, Aftab, Areeb, Karunakaran, Kirti, Pellegrini, Kathryn, Kilembe, William, Karita, Etienne, Gnanakaran, Sandrasegaram, Upadhyay, Amit A., Bosinger, Steven E., Derdeyn, Cynthia A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10627474/ https://www.ncbi.nlm.nih.gov/pubmed/37878666 http://dx.doi.org/10.1371/journal.ppat.1011717

Ejemplares similares

A neutralizing antibody target in early HIV-1 infection was recapitulated in rhesus macaques immunized with the transmitted/founder envelope sequence
por: Welbourn, Sarah, et al.
Publicado: (2022)

Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth
por: Smith, S. Abigail, et al.
Publicado: (2016)

A Mechanistic Understanding of Allosteric Immune Escape Pathways in the HIV-1 Envelope Glycoprotein
por: Sethi, Anurag, et al.
Publicado: (2013)

V2 hotspot optimized MVA vaccine expressing stabilized HIV-1 Clade C envelope Gp140 delays acquisition of heterologous Clade C Tier 2 challenges in Mamu-A*01 negative Rhesus Macaques
por: Styles, Tiffany M., et al.
Publicado: (2022)

VH1-69 Utilizing Antibodies Are Capable of Mediating Non-neutralizing Fc-Mediated Effector Functions Against the Transmitted/Founder gp120
por: Smith, S. Abigail, et al.
Publicado: (2019)

Dynamic electrophoretic fingerprinting of the HIV-1 envelope glycoprotein
por: Stieh, Daniel J, et al.
Publicado: (2013)

Effect of Glycosylation on an Immunodominant Region in the V1V2 Variable Domain of the HIV-1 Envelope gp120 Protein
por: Tian, Jianhui, et al.
Publicado: (2016)

Exploring the Role of Glycans in the Interaction of SARS-CoV-2 RBD and Human Receptor ACE2
por: Nguyen, Kien, et al.
Publicado: (2021)

The C3/465 glycan hole cluster in BG505 HIV-1 envelope is the major neutralizing target involved in preventing mucosal SHIV infection
por: Charles, Tysheena P., et al.
Publicado: (2021)

Essential Dynamics that Drive Sars-Cov-2 Spike Conformational Changes
por: Chakraborty, Srirupa, et al.
Publicado: (2021)

HIV-1 envelope accessible surface and polarity: clade, blood, and brain
por: Sowmya, Gopichandran, et al.
Publicado: (2011)

The Patterns of Coevolution in Clade B HIV Envelope's N-Glycosylation Sites
por: Garimalla, Swetha, et al.
Publicado: (2015)

P09-12. Autologous neutralizing antibodies in early subtype C HIV-1 infection target variable regions of envelope and drive multiple pathways of viral escape
por: Rong, R, et al.
Publicado: (2009)

Antibodies from Rabbits Immunized with HIV-1 Clade B SOSIP Trimers Can Neutralize Multiple Clade B Viruses by Destabilizing the Envelope Glycoprotein
por: van Haaren, M. M., et al.
Publicado: (2021)

Recurrent Signature Patterns in HIV-1 B Clade Envelope Glycoproteins Associated with either Early or Chronic Infections
por: Gnanakaran, S., et al.
Publicado: (2011)

A coarse-grained model for synergistic action of multiple enzymes on cellulose
por: Asztalos, Andrea, et al.
Publicado: (2012)

Exploring the Role of Glycans in the Interaction of SARS-CoV-2 RBD and Human Receptor ACE2
por: Nguyen, Kien, et al.
Publicado: (2021)

Sequential exposure to specific antibody escape mutations may program neutralization breadth during subtype A HIV-1 infection
por: Murphy, MK, et al.
Publicado: (2012)

Comparative Immunogenicity of HIV-1 Clade C Envelope Proteins for Prime/Boost Studies
por: Smith, Douglas H., et al.
Publicado: (2010)

P09-01. Mutation of the gp120 alpha2 helix in early subtype C HIV-1 infection fails to alter neutralization sensitivity or efficiency of in vitro replication
por: Murphy, MK, et al.
Publicado: (2009)

Identification of a clade A HIV envelope immunogen from Protocol G that elicits neutralizing antibodies to tier 2 viruses
por: Hoffenberg, S, et al.
Publicado: (2012)

Antibody responses to V2 loop are induced by CRF01_A E and not Clade B envelopes
por: Karasavvas, N, et al.
Publicado: (2012)

Neutralizing Antibody Responses and Evolution of the Viral Envelope in the Course of HIV-1 Korean Clade B Infection
por: Shin, Bo Gyeong, et al.
Publicado: (2011)

HIV-1 Envelope Glycoproteins from Diverse Clades Differentiate Antibody Responses and Durability among Vaccinees
por: Yates, Nicole L., et al.
Publicado: (2018)

HIV-1 non-macrophage-tropic R5 envelope glycoproteins are not more tropic for entry into primary CD4+ T-cells than envelopes highly adapted for macrophages
por: Musich, Thomas, et al.
Publicado: (2015)

Genome-wide protein phylogenies for four African cichlid species
por: Ramakrishnan Varadarajan, Ajay, et al.
Publicado: (2018)

Viral Escape from Neutralizing Antibodies in Early Subtype A HIV-1 Infection Drives an Increase in Autologous Neutralization Breadth
por: Murphy, Megan K., et al.
Publicado: (2013)

Immunization with HIV-1 envelope T20-encoding DNA vaccines elicits cross-clade neutralizing antibody responses
por: Stenler, S., et al.
Publicado: (2017)

HIV-1 Envelope Glycoprotein Amino Acids Signatures Associated with Clade B Transmitted/Founder and Recent Viruses
por: Kafando, Alexis, et al.
Publicado: (2019)

HIV-1 Envelope Glycosylation and the Signal Peptide
por: Lambert, Gregory S., et al.
Publicado: (2021)

A Signature in HIV-1 Envelope Leader Peptide Associated with Transition from Acute to Chronic Infection Impacts Envelope Processing and Infectivity
por: Asmal, Mohammed, et al.
Publicado: (2011)

Intradermal but not intramuscular modified vaccinia Ankara immunizations protect against intravaginal tier2 simian-human immunodeficiency virus challenges in female macaques
por: Bollimpelli, Venkata S., et al.
Publicado: (2023)

Augmenting the Immune Response against a Stabilized HIV-1 Clade C Envelope Trimer by Silica Nanoparticle Delivery
por: Peterhoff, David, et al.
Publicado: (2021)

Variations in the Biological Functions of HIV-1 Clade C Envelope in a SHIV-Infected Rhesus Macaque during Disease Progression
por: Tso, For Yue, et al.
Publicado: (2013)

Sequential and Simultaneous Immunization of Rabbits with HIV-1 Envelope Glycoprotein SOSIP.664 Trimers from Clades A, B and C
por: Klasse, P. J., et al.
Publicado: (2016)

Stabilization of a soluble, native-like trimeric form of an efficiently cleaved Indian HIV-1 clade C envelope glycoprotein
por: Ahmed, Shubbir, et al.
Publicado: (2017)

Phase I Randomised Clinical Trial of an HIV-1(CN54), Clade C, Trimeric Envelope Vaccine Candidate Delivered Vaginally
por: Lewis, David J., et al.
Publicado: (2011)

Dynamics of Envelope Evolution in Clade C SHIV-Infected Pig-Tailed Macaques during Disease Progression Analyzed by Ultra-Deep Pyrosequencing
por: Tso, For Yue, et al.
Publicado: (2012)

P19-14. Recombinant alphavirus replicon particles as a platform to evaluate immunogenicity of early transmitted clade C virus envelopes
por: Franti, M, et al.
Publicado: (2009)

Promotion of couples’ voluntary HIV counseling and testing: a comparison of influence networks in Rwanda and Zambia
por: Kelley, April L., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_5mnj6f8rvprr331bdgohdfdj75